HalMichaelRosemanMDMPH, FACC, FACP
Cardiology • Nashville, TNAdult Congenital Heart Disease, Preventive Cardiology
Preventive Cardiologist, Cardiology Wellness Center
Dr. Roseman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2400 Patterson St
Suite 218
Nashville, TN 37203Phone+1 615-884-4425Fax+1 615-891-7961
Education & Training
Massachusetts General HospitalFellowship, Cardiovascular Disease, 1987 - 1988
Brown UniversityFellowship, Cardiovascular Disease, 1985 - 1987
Yale-New Haven Medical Center (Waterbury)Residency, Internal Medicine, 1983 - 1985
Yale UniversityMPH, Epidemiology of cardiovascular diseases, 1982 - 1983
Yale UniversityM.P.H., 1982 - 1983- USPHS HospitalResidency, Internal Medicine, 1980 - 1981
University of TennesseeInternship, Internal Medicine, 1979 - 1980
University of Tennessee Health Science Center College of MedicineClass of 1979- University of PennsylvaniaB.A., Sociology: Social and Political Theory, 1971 - 1975
Certifications & Licensure
CA State Medical License 1981 - Present
NY State Medical License 1981 - 2026
MA State Medical License 1988 - 2025
OR State Medical License 2024 - 2025
TN State Medical License 1982 - 2025
AZ State Medical License 2021 - 2023
CO State Medical License 1991 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification athenaClinicals EHR, athenahealth, Inc, 2012-2013
- Fellow American College of Angiology, 1992
- Fellow American College of Cardiology, 1991
- Join now to see all
Clinical Trials
- Sitagliptin Cardiovascular Outcomes Study (MK-0431-082) Start of enrollment: 2008 Dec 10
- Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Publications & Presentations
PubMed
- 7 citationsProgression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management.Hal M Roseman
Journal of Managed Care Pharmacy. 2005-08-01 - 1 citationsUnresolved Heart Block in Lyme Carditis: A Case Report.Shannon Baron, Subash Nepal, Madhab Lamichhane, Hal Roseman
Cureus. 2022-09-01 - 14 citationsCombination Therapy With Ezetimibe/Simvastatin Versus Statin Monotherapy for Low-Density Lipoprotein Cholesterol Reduction and Goal Attainment in a Real-World Clinical...Howard S. Friedman, Srinivasan Rajagopalan, Jaime P. Barnes, Hal Roseman
Clinical Therapeutics. 2011-02-01
Journal Articles
- Combination Therapy with Ezetimibe/Simvastatin vs Statin Monotherapy for LDL Cholesterol Reduction and Goal Attainment in a Real-World Clinical SettingFriedman HS, Rajagopaian S, Barnes JP, Roseman H, Clin Therapeutics, 1/1/2011
Professional Memberships
- Fellow
- Specialist, by test certification
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
